The Gut-Liver Axis - The role of the Microbiome in Toxicity @AgeManagmentMedicineGroup
The Gut-Liver Axis - The role of the Microbiome in Toxicity  @AgeManagmentMedicineGroup
Uploaded October 2021 | Updated September 2026, 17 hours ago
The Gut-Liver Axis - The role of the Microbiome in Toxicity


One of the foundational therapeutics in functional medicine is supporting detoxification for our patients. Addressing the microbiome and biofilms is fundamental for supporting detoxification, immune system function, healthy inflammatory response, and lasting therapeutic effects. Failure to address the microbiome can create an obstacle to successful detoxification. Join Dr. Jocelyn Strand, ND, Director of Clinical Education for Biocidin® as she discusses research on the role of the microbiome and biofilms in addressing toxicity.


THE AGE MANAGEMENT MEDICINE DIFFERENCE
It’s a progressive, preventative, proactive specialty focused on health, not disease. Age Management Medicine delivers measurable, life-changing patient outcomes—optimizing health and delaying or removing degenerative aging—using precision medicine, breakthrough technologies, evidence-based/customized modalities, and solid science.

Age Management Medicine, practiced part or full-time, leads you onto a different path—where you regain command of your practice and medical decision-making. It’s medical excellence at every turn with no insurance red tape, less stress, better patient care, a restored patient-physician relationship, and a reignited medical passion.

The Age Management Medicine Group (AMMG) provides:
— CME-accredited Conferences for Physicians, Pharmacists and Nurses
— Education and Certification in Age Management Medicine
— Online CME Courses with an Age Management Medicine focus.

Visit us at agemed.org
The Gut-Liver Axis - The role of the Microbiome in Toxicity
AMMG - CME Conferences - Physician Education |

The Gut-Liver Axis - The role of the Microbiome in Toxicity

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER